background image

Paid Clinical Trials Bowling Green

Discover 62 paid clinical trials in Bowling Green, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Barzolvolimab in Patients With Atopic Dermatitis

for
Atopic Dermatitis
Location: 35 recruiting locations
Sponsor: Celldex Therapeutics

Sex: All

Age: 18+

Code: NCT06727552

Phase2, Recruiting
Active & Responsive

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

for
Atopic Dermatitis
Location: 48 recruiting locations
Sponsor: Eli Lilly and Company

Sex: All

Age: 12+

Code: NCT07006792

Recruiting
Active & Responsive

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

for
Arthritis, Rheumatoid
Location: 35 recruiting locations
Sponsor: Crescendo Bioscience

Sex: All

Age: 18 - 70+

Code: NCT02832297

Recruiting
Active & Responsive

A Brief Intervention for Alcohol Users With Interpersonal Trauma

for
Heavy Drinking, Alcohol Drinking, Substance Use,
Location: 1 recruiting location
Sponsor: Western Kentucky University

Sex: All

Age: 18 - 25

Code: NCT05414344

Recruiting
Active & Responsive

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for
Psoriasis, Overweight or Obesity
Location: 41 recruiting locations
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06857942

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

for
Atoptic Dermatitis
Location: 20 recruiting locations
Sponsor: Evommune, Inc.

Sex: All

Age: 18+

Code: NCT07150845

Phase2, Recruiting
Active & ResponsiveNew

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

for
SARS-CoV-2
Location: 10 recruiting locations
Sponsor: ModernaTX, Inc.

Sex: All

Age: 50 - 64

Code: NCT07266558

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: 133 recruiting locations
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: 143 recruiting locations
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy Following Chemoimmunotherapy

for
Non-small Cell Lung Cancer
Location: 3 recruiting locations
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06841055

Phase2, Recruiting